Elevation of VWF and potential reduction in ADAMTS13 essentially represent biomarkers of endothelial dysfunction, as most recently typified in COVID-19 (Coronavirus Disease 2019) [10]. This evidence concerns the gene ADAMTS13 and endothelial dysfunction.